These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25749751)

  • 1. Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?
    Bernardy NC; Friedman MJ
    Curr Psychiatry Rep; 2015 Apr; 17(4):564. PubMed ID: 25749751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
    Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials.
    Sullivan GM; Neria Y
    Curr Opin Investig Drugs; 2009 Jan; 10(1):35-45. PubMed ID: 19127485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considering future pharmacotherapy for PTSD.
    Friedman MJ; Bernardy NC
    Neurosci Lett; 2017 May; 649():181-185. PubMed ID: 27890743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine for the treatment of posttraumatic stress disorder.
    Lake EP; Mitchell BG; Shorter DI; Kosten T; Domingo CB; Walder AM
    Am J Addict; 2019 Feb; 28(2):86-91. PubMed ID: 30664299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
    Price CM; Feduccia AA; DeBonis K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder.
    Naglich AC; Bozeman S; Brown ES; Adinoff B
    Alcohol Alcohol; 2019 Jul; 54(4):428-434. PubMed ID: 31185085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy.
    Hamner MB; Hernandez-Tejada MA; Zuschlag ZD; Agbor-Tabi D; Huber M; Wang Z
    J Clin Psychopharmacol; 2019; 39(2):153-157. PubMed ID: 30640209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient journey of civilian adults diagnosed with posttraumatic stress disorder-A chart review study.
    Davis LL; Urganus A; Gagnon-Sanschagrin P; Maitland J; Bedard J; Bellefleur R; Cloutier M; Guérin A; Aggarwal J
    Curr Med Res Opin; 2024 Mar; 40(3):505-516. PubMed ID: 38258436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Medication Prescribing in Patients With PTSD From 2009 to 2018: A National Veterans Administration Study.
    Holder N; Woods A; Neylan TC; Maguen S; Seal KH; Bernardy N; Wiechers I; Ryder A; Urbieta AM; Cohen BE
    J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review.
    Sagarwala R; Nasrallah HA
    Ann Clin Psychiatry; 2019 Nov; 31(4):292-297. PubMed ID: 31675389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging genetics to enhance the efficacy of PTSD pharmacotherapies.
    Miller MW
    Neurosci Lett; 2020 May; 726():133562. PubMed ID: 29689343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies.
    Gasparyan A; Navarro D; Navarrete F; Manzanares J
    Neuropharmacology; 2022 Nov; 218():109211. PubMed ID: 35973598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychotherapeutic and psychopharmacological treatment of PTSD].
    Carlsson J; Sandahl H
    Ugeskr Laeger; 2022 Apr; 184(14):. PubMed ID: 35410657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.
    Norred MA; Zuschlag ZD; Hamner MB
    Drugs; 2024 Feb; 84(2):149-164. PubMed ID: 38413493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder.
    Abdallah CG; Averill LA; Akiki TJ; Raza M; Averill CL; Gomaa H; Adikey A; Krystal JH
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():171-189. PubMed ID: 30216745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial.
    Dunlop BW; Rakofsky JJ; Newport DJ; Mletzko-Crowe T; Barone K; Nemeroff CB; Harvey PD
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):172-179. PubMed ID: 33587394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in temporal attention inhibition following prolonged exposure and sertraline in the treatment of PTSD.
    Echiverri-Cohen A; Zoellner LA; Gallop R; Feeny N; Jaeger J; Bedard-Gilligan M
    J Consult Clin Psychol; 2016 May; 84(5):415-26. PubMed ID: 26900894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidenced-Based Treatment of Posttraumatic Stress Disorder: An Updated Review of Validated Psychotherapeutic and Pharmacological Approaches.
    Charney ME; Hellberg SN; Bui E; Simon NM
    Harv Rev Psychiatry; 2018; 26(3):99-115. PubMed ID: 29734225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-traumatic Stress Disorder in Middle Age and Beyond.
    Marshall LL; Hayslett RL
    Sr Care Pharm; 2021 Apr; 36(4):191-207. PubMed ID: 33766192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.